Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
6
|
Zenith Epigenetics
|
Feb 03, 2019 04:01AM
|
Re: You're right 10bagr, you didn't sway me....
|
3
|
Resverlogix Corp.
|
Feb 02, 2019 07:36PM
|
Re: You're right 10bagr, you didn't sway me....
|
2
|
Resverlogix Corp.
|
Feb 02, 2019 02:40AM
|
Re: You're right 10bagr, you didn't sway me....
|
7
|
Resverlogix Corp.
|
Feb 01, 2019 04:49PM
|
Re: Back on board
|
2
|
Resverlogix Corp.
|
Feb 01, 2019 03:46PM
|
Re: You're right 10bagr, you didn't sway me....
|
3
|
Resverlogix Corp.
|
Feb 01, 2019 03:34PM
|
Re: You're right 10bagr, you didn't sway me....
|
2
|
Resverlogix Corp.
|
Feb 01, 2019 03:13PM
|
Re: You're right 10bagr, you didn't sway me....
|
3
|
Resverlogix Corp.
|
Feb 01, 2019 02:46PM
|
Re: You're right 10bagr, you didn't sway me....
|
3
|
Resverlogix Corp.
|
Feb 01, 2019 03:03AM
|
Re: My email to Sarah...the latest
|
4
|
Resverlogix Corp.
|
Feb 01, 2019 02:41AM
|
Re: We need news on the status of the Third Eye loan....
|
3
|
Resverlogix Corp.
|
Jan 31, 2019 06:38PM
|
$6.6 million financing with Hepalink
|
3
|
Resverlogix Corp.
|
Jan 31, 2019 06:09PM
|
Re: Why news has to come out Thursday imo....walking in the enemy's shoes
|
2
|
Resverlogix Corp.
|
Jan 30, 2019 02:52PM
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
3
|
Zenith Epigenetics
|
Jan 30, 2019 10:04AM
|
Re: Adjudication
|
3
|
Resverlogix Corp.
|
Jan 30, 2019 01:57AM
|
Re: What impact would a PR like this have?
|
2
|
Resverlogix Corp.
|
Jan 29, 2019 04:30PM
|
Re: What impact would a PR like this have?
|
4
|
Resverlogix Corp.
|
Jan 29, 2019 04:09PM
|
Re: Why news has to come out Thursday imo....walking in the enemy's shoes
|
3
|
Resverlogix Corp.
|
Jan 29, 2019 02:15PM
|
Re: What impact would a PR like this have?
|
2
|
Resverlogix Corp.
|
Jan 29, 2019 01:33PM
|
Re: Price boxed in....
|
5
|
Resverlogix Corp.
|
Jan 28, 2019 10:34AM
|